Sales Rise 11%, but Chong Kun Dang’s Q2 Operating Profit Slips 10%
Chong Kun Dang posted higher sales in the second quarter of this year, but its operating profit fell 10% from a year earlier.
Search results for "operating profit"
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%
Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major technology-transfer agreement with Eli Lilly.
Samsung Biologics Posts 586.4 Billion Won Q2 Profit, But Labor Uncertainty Looms
Samsung Biologics reported second-quarter revenue in the 1.3 trillion won range this year, a 30% increase from the same...
MS Bio Pursues IPO to Fuel Expansion into Amniotic Lenses, Aesthetics, and Global Markets
MS Bio, a specialized manufacturer of human tissue graft materials and medical devices, is leveraging its upcoming...
The AI-Powered Future of K-Beauty: APR Bets Big on Smart Hardware and Custom Routines
K-beauty’s growth engine is rapidly expanding from traditional cosmetics into at-home beauty devices.
Reaching Beyond Hospitals: Wontech Targets Global Home Beauty Market for Next Growth Engine
Medical aesthetic device manufacturer Wontech is expanding beyond its traditional hospital- and clinic-centered B2B...
Celltrion Targets 33% Shareholder Payout Ratio, Adds 100 Billion Won Share Buyback
Celltrion announced on Aug. 31 that it will return approximately one-third of its annual consolidated net profit to...
Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group
Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of...
Even Seoul-Area Tertiary Hospitals Fall Into the Red as 253 Institutions Record a Nine-Year Financial Slide
It is a familiar refrain in the healthcare industry that managing hospital finances has grown exceptionally difficult.
Celltrion Chairman Seo Jung-jin Forgoes Summer Vacation for Global Business Tour Targeting Record Second Half
Celltrion Group Chairman Seo Jung-jin will forgo his summer vacation this August to embark on an intensive overseas...